References
Study Group of Physicians, Newcastle-Upon-Tyne: Trial of clofibrate in treatment of ischaemic heart disease. British Medical Journal 2: 767–775 (1971).
Scottish Society of Physicians: Ischaemic heart disease: A secondary prevention trial using clofibrate. British Medical Journal 2: 775–784 (1971).
Krasno, L.R. and Kidera, G.J.: Clofibrate in coronary heart disease: Effect on morbidity and mortality. Journal of American Medical Association 219: 845–851 (1972).
The Coronary Drug Project Research Group: Clofibrate and niacin in coronary heart disease. Journal of American Medical Association 231: 360–381 (1975).
Carlson, L.A.; Danielson, M.; Ekberg, I. et al.: Reduction of myocardial re-infarction by the combined treatment with clofibrate and nicotinic acid. Atherosclerosis 28: 81–86 ( 1977).
Door, A.E.; Gundersen, K.; Schneider, J.C. et al.: Colestipol hydrochloride in hypercholesterolemic patients. Effect on serum cholesterol and mortality. Journal of Chronic Diseases 31: 5–14 (1978).
Committee of Principal Investigators: A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. British Heart Journal 40: 1069–1118 (1978).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Simons, L. Lipid Lowering Drugs: What is Their Place in Therapeutics?. Drugs 17, 501–506 (1979). https://doi.org/10.2165/00003495-197917060-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-197917060-00006